PEN Penumbra posts 5 percent Q4 2025 EPS beat shares register small gain in todays trading SABSW SAB management highlights upcoming biotherapeutic pipeline plans as quarterly earnings details are not yet available The growth trajectory Huntington HBANZ is on and where it leads Market Focus 20260508 What makes SPACSphere SSAC a stronger buy than it appears Trend Strengthens 20260508 Cerebras Raises IPO Target to 55 Billion Eyes 40 Billion Valuation Amid AI Chip Frenzy Hedge Fund Managers Eye Bearish Bets Amid AI Hype How Short Sellers Are Spotting Overvalued Tech Modella Emerges as Controlling Force in HighStakes Revival of Former WH Smith Chain